Statements (14)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:alsoKnownAs |
gptkb:SN-38-PEG
|
| gptkbp:chemicalClass |
polymer-drug conjugate
|
| gptkbp:clinicalTrialPhase |
Phase 1/2
|
| gptkbp:containsActiveMoiety |
gptkb:SN-38
|
| gptkbp:developedBy |
gptkb:Tarveda_Therapeutics
|
| https://www.w3.org/2000/01/rdf-schema#label |
PEN-866
|
| gptkbp:indication |
solid tumors
|
| gptkbp:mechanismOfAction |
topoisomerase I inhibitor prodrug
|
| gptkbp:routeOfAdministration |
intravenous
|
| gptkbp:status |
investigational drug
|
| gptkbp:target |
tumor-associated heat shock protein 90 (HSP90)
|
| gptkbp:bfsParent |
gptkb:Tarveda_Therapeutics
|
| gptkbp:bfsLayer |
6
|